Fierce Pharma
DECEMBER 3, 2024
Over the last two-plus years, as Eli Lilly and Novo Nordisk have battled for their share of the massive weight loss market and patients wondered which company’s products were more effective, there | Eli Lilly revealed results from a study that showed its obesity drug Zepbound was 47% more effective than Novo’s Wegovy in helping patients lose weight.
MedCity News
DECEMBER 3, 2024
GE HealthCare made a slew of announcements at RSNA 2024, including an acquisition, new machines for mammography and SPECT/CT imaging, and new AI features to help improve radiologist workflows. The post 4 Announcements GE HealthCare Made at RSNA 2024 appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 3, 2024
Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the last biosimilar in its portfolio, in turn freeing up the company to go a | Coherus has agreed to sell its Neulasta biosimilar Udenyca to Intas Pharmaceuticals for up to $558.4 million. The company plans to use the proceeds from the sale to pay off debt and fuel development opportunities for its branded cancer med Loqtorzi.
MedCity News
DECEMBER 3, 2024
Keros Therapeutics will present Phase 2 data for the drug, elritercept, at the annual meeting of the American Society of Hematology. Meanwhile, the Takeda deal enables Keros to focus on two wholly owned assets, one of which could compete with a Merck drug approved earlier this year. The post Takeda Pays $200M for Keros Therapeutics Drug With Potential in Blood Cancers and Beyond appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
DECEMBER 3, 2024
On the heels of similar deals in the U.S. and the EU, the U.K. is filling up its coffers with doses of bird flu immunizations from Australia’s CSL Seqirus. | On the heels of similar deals in the U.S. and the European Union, the United Kingdom is filling up its coffers with doses of bird flu immunizations from Australia’s CSL Seqirus. To prepare for a potential future pandemic, the U.K. has inked an accord with CSL Seqirus to acquire more than 5 million doses of the company’s H5 influenza shot.
MedCity News
DECEMBER 3, 2024
When you combine clean data with longitudinal patient records and transparent access — that’s when you start seeing real transformation in care delivery. The post Set the Data Free: Break the Chains of Information Silos appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 3, 2024
Incorporating PbD into the software development process of EHR systems presents a strategy to protect information starting from the initial stages of development and, throughout the entire lifecycle of the software. The post Boosting HIPAA Compliance in EHR Systems with Privacy-by-Design appeared first on MedCity News.
pharmaphorum
DECEMBER 3, 2024
Tune in to the podcast interview with Dr Sharmeen Roy to learn more about precision dosing and how DoseMe is providing effective and safe treatment for all through personalised dosing solutions.
PharmaTimes
DECEMBER 3, 2024
Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for Health and Care Excellence (NICE) and is now available through the NHS.
MedCity News
DECEMBER 3, 2024
Merative, a data, analytics and technology provider, is Morgan Health’s eighth portfolio company. The investment will help accelerate growth. The post Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTech
DECEMBER 3, 2024
Edwin Stone, Bernard Sagaert, and Khaled Yamout go behind the headlines to discuss what the ongoing measles outbreak in the UK means for pandemic preparedness and anti-vaccination trends; new mRNA approaches; and what Roche’s acquisition of Poseida means for complex cell therapies.
Eversana Intouch
DECEMBER 3, 2024
EVERSANA INTOUCH recently hosted an insightful panel at the 2024 ProcureCon Marketing conference in Los Angeles. The panel, titled “The Balancing Act: Sourcing & Pricing Meet Innovation in Life Sciences,” brought together industry leaders to discuss the intersection of cost efficiency and innovation in the dynamic field of life sciences.
European Pharmaceutical Review
DECEMBER 3, 2024
Novartis Pharmaceuticals Corporation (a subsidiary of Novartis AG), is set to collaborate with PTC Therapeutics to develop the potential first oral disease-modifying therapy for Huntington’s disease. The global license and collaboration agreement is focused on PTC Therapeutics’ PTC518 Huntington’s disease programme. PTC will receive $1.0 billion upfront.
pharmaphorum
DECEMBER 3, 2024
Patients in England with a rare form of eye cancer will be able to access Kimmtrak, a TCR therapy from Immunocore, after NICE changes its position
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Commerce
DECEMBER 3, 2024
The agreement provides PTC with $1 billion in cash once deal closes, and is centered around PTC518's development, manufacturing and commercialization.
pharmaphorum
DECEMBER 3, 2024
Cytokinetics should hear back from the FDA next September about its application for Camzyos rival aficamten in obstructive hypertrophic cardiomyopathy
Clarify Health
DECEMBER 3, 2024
The rising cost of healthcare is a perennial challenge for employers and health plans. The average cost of employer-sponsored healthcare is projected to rise 9% in 2025 , higher than the 6.4% increase from the previous year and the highest increase in a decade. This means CFOs and benefits leaders will be under even more financial pressure as they plan budgets and healthcare benefits for the coming year.
pharmaphorum
DECEMBER 3, 2024
Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415m.
Contrarian Sales Techniques
DECEMBER 3, 2024
So, you’re thinking about starting a career in pharmaceutical sales ? Great choice. It’s not just another job—it’s a chance to build a career where you can grow, earn well, and genuinely make a difference. With Malaysia’s healthcare industry expanding rapidly, companies are always on the lookout for talented people who can help bring their products to the market.
PharmExec
DECEMBER 3, 2024
The breakthrough designation is based on data from the expansion cohort of a Phase I/II study evaluating sacituzumab tirumotecan in patients with epidermal growth factor receptor-mutated non-small cell lung cancer.
Nixon Gwilt Law
DECEMBER 3, 2024
November 2024 marks 20 months since the venture debt markets were shaken up by a string of notable technology bank struggles (think Silicon Valley Bank, among others), where some expected venture debt financing to disappear. Fast forward to today, and although the remnants of macroeconomic headwinds remain, the venture debt markets are on the upswing, with $23.5B raised in the U.S. in H1 2024 compared to $27.1B raised in all of 2023, according to J.P.
PharmExec
DECEMBER 3, 2024
In this part of his Pharmaceutical Executive video interview, Bill Grambley, CEO of AllazoHealth, explains how AI can be leveraged to create highly personalized patient engagement strategies, tailored to individual needs and preferences.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
DECEMBER 3, 2024
Many machines are required for pharmaceutical milling processes. Can you reduce that number, streamline operations and improve efficiency?
Pharmaceutical Commerce
DECEMBER 3, 2024
Dr. Reddy’s immuno-oncology drug for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma will be marketed under the brand name Zytorvi.
Pharmaceutical Technology
DECEMBER 3, 2024
Turkiye’s pharmaceutical industry has grappled with significant economic challenges such as the frequent upward revision of the pharmaceutical Euro exchange rate.
PharmaVoice
DECEMBER 3, 2024
After failing a mid-stage trial, the biotech shifted course and is now targeting females with the goal of proving gender can play a role in depression outcomes.
Pharmaceutical Technology
DECEMBER 3, 2024
Olema Oncology and Novartis have signed a clinical trial collaboration and supply agreement for a Phase III trial in metastatic breast cancer.
PharmExec
DECEMBER 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
DECEMBER 3, 2024
Lundbeck has completed the acquisition of all outstanding shares of Longboard Pharmaceuticals, to bolster the neuro-rare disease sector.
PharmExec
DECEMBER 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
270 
Let's personalize your content